These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24735096)

  • 21. Highly successful treatment outcome of multidrug-resistant and genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains in Rwanda.
    Muvunyi CM; Ngabonziza JCS; Uwimana I; Harelimana JD; Mucyo Y; Sebatunzi OR; Muvunyi TZ; Seruyange E; Masaisa F; Mazarati JB; Gasana M
    Trop Med Int Health; 2019 Jul; 24(7):879-887. PubMed ID: 31066112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time to sputum culture conversion and its associated factors among multidrug-resistant tuberculosis patients in Eastern Africa: A systematic review and meta-analysis.
    Assemie MA; Alene M; Petrucka P; Leshargie CT; Ketema DB
    Int J Infect Dis; 2020 Sep; 98():230-236. PubMed ID: 32535296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Velayutham B; Nair D; Kannan T; Padmapriyadarsini C; Sachdeva KS; Bency J; Klinton JS; Haldar S; Khanna A; Jayasankar S; Swaminathan S
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):1671-1676. PubMed ID: 27931345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999.
    Toungoussova OS; Nizovtseva NI; Mariandyshev AO; Caugant DA; Sandven P; Bjune G
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):174-9. PubMed ID: 14735405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse treatment outcomes in multidrug resistant tuberculosis go beyond the microbe-drug interaction: Results of a multiple correspondence analysis.
    Tobón Á; Rueda J; Cáceres DH; Mejía GI; Zapata EM; Montes F; Ospina A; Fadul S; Paniagua L; Robledo J
    Biomedica; 2020 Dec; 40(4):616-625. PubMed ID: 33275341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of extensively drug-resistant pulmonary tuberculosis.
    Kliiman K; Altraja A
    Ann Intern Med; 2009 Jun; 150(11):766-75. PubMed ID: 19487711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India.
    Dhakulkar S; Das M; Sutar N; Oswal V; Shah D; Ravi S; Vengurlekar D; Chavan V; Rebello L; Meneguim AC; Iyer A; Mansoor H; Kalon S; Acharya S; Ferlazzo G; Isaakidis P; Thakur HP
    PLoS One; 2021; 16(2):e0246639. PubMed ID: 33600431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Summaries for patients. Treatment outcomes for patients with multidrug-resistant tuberculosis.
    Ann Intern Med; 2006 May; 144(9):I18. PubMed ID: 16670128
    [No Abstract]   [Full Text] [Related]  

  • 32. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
    Mitnick C; Bayona J; Palacios E; Shin S; Furin J; Alcántara F; Sánchez E; Sarria M; Becerra M; Fawzi MC; Kapiga S; Neuberg D; Maguire JH; Kim JY; Farmer P
    N Engl J Med; 2003 Jan; 348(2):119-28. PubMed ID: 12519922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.
    Velásquez GE; Calderon RI; Mitnick CD; Becerra MC; Huang CC; Zhang Z; Contreras CC; Yataco RM; Galea JT; Lecca LW; Murray MB
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6766-6773. PubMed ID: 27600032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary tuberculosis in north India.
    Sethi S; Mewara A; Dhatwalia SK; Singh H; Yadav R; Singh K; Gupta D; Wanchu A; Sharma M
    BMC Infect Dis; 2013 Mar; 13():137. PubMed ID: 23497169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?
    Bastard M; Bonnet M; du Cros P; Khamraev AK; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Telnov A; Sanchez-Padilla E; Hewison C; Varaine F
    Am J Respir Crit Care Med; 2015 Feb; 191(3):355-8. PubMed ID: 25635495
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
    Goswami A; Chakraborty U; Mahapatra T; Mahapatra S; Mukherjee T; Das S; Das A; Dey SK; Ray S; Bhattacharya B; Pal NK
    PLoS One; 2014; 9(10):e109563. PubMed ID: 25289974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China.
    Lu P; Liu Q; Martinez L; Yang H; Lu W; Ding X; Zhu L
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
    Cegielski JP; Kurbatova E; van der Walt M; Brand J; Ershova J; Tupasi T; Caoili JC; Dalton T; Contreras C; Yagui M; Bayona J; Kvasnovsky C; Leimane V; Kuksa L; Chen MP; Via LE; Hwang SH; Wolfgang M; Volchenkov GV; Somova T; Smith SE; Akksilp S; Wattanaamornkiet W; Kim HJ; Kim CK; Kazennyy BY; Khorosheva T; Kliiman K; Viiklepp P; Jou R; Huang AS; Vasilyeva IA; Demikhova OV; ; Lancaster J; Odendaal R; Diem L; Perez TC; Gler T; Tan K; Bonilla C; Jave O; Asencios L; Yale G; Suarez C; Walker AT; Norvaisha I; Skenders G; Sture I; Riekstina V; Cirule A; Sigman E; Cho SN; Cai Y; Eum S; Lee J; Park S; Jeon D; Shamputa IC; Metchock B; Kuznetsova T; Akksilp R; Sitti W; Inyapong J; Kiryanova EV; Degtyareva I; Nemtsova ES; Levina K; Danilovits M; Kummik T; Lei YC; Huang WL; Erokhin VV; Chernousova LN; Andreevskaya SN; Larionova EE; Smirnova TG
    Clin Infect Dis; 2016 Feb; 62(4):418-430. PubMed ID: 26508515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine.
    Pedersen OS; Butova T; Kapustnyk V; Miasoiedov V; Kuzhko M; Hryshchuk L; Kornaha S; Borovok N; Raznatovska O; Fedorec A; Bogomolov A; Tkhorovskiy M; Akymenko O; Klymenko I; Kulykova O; Karpenko Z; Shapoval T; Chursina N; Kondratyuk N; Parkhomenko O; Sazonenko I; Ostrovskyy M; Makoida I; Markovtsiy L; Skryp V; Lubenko V; Hrankina N; Bondarenko L; Hlynenko V; Dahl VN; Butov D
    Clin Microbiol Infect; 2024 Mar; 30(3):360-367. PubMed ID: 38065363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.